SHIKARI® Q-ADA - Adalimumab (Humira®) ELISA

SHIKARI Q-ADA Instructions for Use PDF file

Enzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma.

The Matriks Biotek Shikari adalimumab ELISA has been especially developed for the quantitative analysis of free adalimumab in serum and plasma samples.

SHIKARI S-ATA Instructions for Use PDF file

Enzyme immunoassay for the qualitative determination of antibodies to adalimumab in serum and plasma.

Adalimumab (Humira®) was associated to the development of anti-Adalimumab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Humira®. This might lead to severe complications. The Matriks Biotek shikari Antibody to Adalimumab ELISA Kit can be efficiently used for monitoring anti-Adalimumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Adalimumab antibodies.